CSPC Pharmaceutical Group Limited (FRA:CVGU)
Germany
· Delayed Price · Currency is EUR 3.220
-0.020 (-0.62%)
At close: Dec 4, 2025
CSPC Pharmaceutical Group Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 9,734 | 6,860 | 9,962 | 11,725 | 11,381 | 9,996 | Upgrade
|
| Market Cap Growth | 32.48% | -31.14% | -15.04% | 3.02% | 13.87% | -24.60% | Upgrade
|
| Enterprise Value | 8,817 | 5,647 | 8,640 | 10,147 | 9,947 | 9,236 | Upgrade
|
| Last Close Price | 3.16 | 2.11 | 2.92 | 3.47 | 3.10 | - | Upgrade
|
| PE Ratio | 20.02 | 11.98 | 13.30 | 14.19 | 14.67 | 15.47 | Upgrade
|
| PS Ratio | 3.10 | 1.79 | 2.48 | 2.79 | 2.95 | 3.20 | Upgrade
|
| PB Ratio | 2.33 | 1.53 | 2.23 | 2.73 | 3.07 | 3.46 | Upgrade
|
| P/TBV Ratio | 2.68 | 1.76 | 2.53 | 3.08 | 3.24 | 3.68 | Upgrade
|
| P/FCF Ratio | - | 20.58 | 30.56 | 15.99 | 25.49 | 14.83 | Upgrade
|
| P/OCF Ratio | - | 11.43 | 18.68 | 11.33 | 17.73 | 11.84 | Upgrade
|
| EV/Sales Ratio | 2.79 | 1.47 | 2.15 | 2.42 | 2.58 | 2.96 | Upgrade
|
| EV/EBITDA Ratio | 13.19 | 6.62 | 8.53 | 9.83 | 10.31 | 11.98 | Upgrade
|
| EV/EBIT Ratio | 17.54 | 7.95 | 9.65 | 11.07 | 11.50 | 13.48 | Upgrade
|
| EV/FCF Ratio | - | 16.94 | 26.50 | 13.83 | 22.27 | 13.70 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.02 | 0.02 | 0.02 | 0.00 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.09 | 0.08 | 0.09 | 0.08 | 0.01 | 0.05 | Upgrade
|
| Debt / FCF Ratio | - | 0.20 | 0.28 | 0.11 | 0.03 | 0.06 | Upgrade
|
| Asset Turnover | - | 0.64 | 0.71 | 0.81 | 0.86 | 0.89 | Upgrade
|
| Inventory Turnover | - | 2.78 | 3.26 | 3.45 | 3.10 | 2.85 | Upgrade
|
| Quick Ratio | - | 1.95 | 2.32 | 2.39 | 2.47 | 2.22 | Upgrade
|
| Current Ratio | - | 2.27 | 2.63 | 2.67 | 2.81 | 2.53 | Upgrade
|
| Return on Equity (ROE) | - | 12.60% | 18.22% | 21.32% | 22.79% | 24.54% | Upgrade
|
| Return on Assets (ROA) | - | 7.40% | 9.96% | 11.04% | 12.05% | 12.13% | Upgrade
|
| Return on Capital (ROIC) | - | 9.57% | 12.91% | 14.29% | 15.52% | 15.86% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 15.40% | 19.40% | 20.60% | 22.70% | 23.00% | Upgrade
|
| Earnings Yield | 5.00% | 8.35% | 7.52% | 7.05% | 6.82% | 6.46% | Upgrade
|
| FCF Yield | - | 4.86% | 3.27% | 6.26% | 3.92% | 6.74% | Upgrade
|
| Dividend Yield | 2.64% | 1.53% | 1.13% | 0.75% | 0.68% | - | Upgrade
|
| Payout Ratio | - | 74.72% | 46.42% | 34.42% | 30.16% | 29.61% | Upgrade
|
| Buyback Yield / Dilution | 2.93% | 1.14% | 0.38% | 0.29% | 0.01% | 0.00% | Upgrade
|
| Total Shareholder Return | 5.57% | 2.67% | 1.51% | 1.04% | 0.69% | 0.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.